Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 2
1995 1
1996 1
1998 1
1999 1
2000 1
2004 1
2006 1
2007 1
2013 1
2014 2
2015 1
2017 3
2018 2
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

17 results
Results by year
Filters applied: . Clear all
Page 1
Randomized Clinical Trial of Sodium Polystyrene Sulfonate for the Treatment of Mild Hyperkalemia in CKD.
Lepage L, Dufour AC, Doiron J, Handfield K, Desforges K, Bell R, Vallée M, Savoie M, Perreault S, Laurin LP, Pichette V, Lafrance JP. Lepage L, et al. Clin J Am Soc Nephrol. 2015 Dec 7;10(12):2136-42. doi: 10.2215/CJN.03640415. Epub 2015 Nov 17. Clin J Am Soc Nephrol. 2015. PMID: 26576619 Free PMC article. Clinical Trial.
BACKGROUND AND OBJECTIVES: Hyperkalemia affects up to 10% of patients with CKD. Sodium polystyrene sulfonate has long been prescribed for this condition, although evidence is lacking on its efficacy for the treatment of mild hyperkalemia over several days. ...There was a t …
BACKGROUND AND OBJECTIVES: Hyperkalemia affects up to 10% of patients with CKD. Sodium polystyrene sulfonate has long been prescribed …
Compared effects of calcium and sodium polystyrene sulfonate on mineral and bone metabolism and volume overload in pre-dialysis patients with hyperkalemia.
Nakayama Y, Ueda K, Yamagishi SI, Sugiyama M, Yoshida C, Kurokawa Y, Nakamura N, Moriyama T, Kodama G, Minezaki T, Ito S, Nagata A, Taguchi K, Yano J, Kaida Y, Shibatomi K, Fukami K. Nakayama Y, et al. Clin Exp Nephrol. 2018 Feb;22(1):35-44. doi: 10.1007/s10157-017-1412-y. Epub 2017 Apr 18. Clin Exp Nephrol. 2018. PMID: 28421299 Clinical Trial.
BACKGROUND: Hyperkalemia is prevalent in end-stage renal disease patients, being involved in life-threatening arrhythmias. Although polystyrene sulfonate (PS) is commonly used for the treatment of hyperkalemia, direct comparison of effects between calcium and sodium PS (CP …
BACKGROUND: Hyperkalemia is prevalent in end-stage renal disease patients, being involved in life-threatening arrhythmias. Although polys …
Randomized, Controlled Trial of the Effect of Dietary Potassium Restriction on Nerve Function in CKD.
Arnold R, Pianta TJ, Pussell BA, Kirby A, O'Brien K, Sullivan K, Holyday M, Cormack C, Kiernan MC, Krishnan AV. Arnold R, et al. Clin J Am Soc Nephrol. 2017 Oct 6;12(10):1569-1577. doi: 10.2215/CJN.00670117. Epub 2017 Sep 11. Clin J Am Soc Nephrol. 2017. PMID: 28893921 Free PMC article. Clinical Trial.
The intervention arm (n=23) was prescribed a diet focusing on potassium restriction to meet a monthly serum potassium level of 4.5 mEq/L, with oral sodium polystyrene sulfonate provided if dietary advice failed to achieve the target. ...
The intervention arm (n=23) was prescribed a diet focusing on potassium restriction to meet a monthly serum potassium level of 4.5 mEq/L, wi …
Single and multiple exposure tolerance study of polystyrene sulfonate gel: a phase I safety and colposcopy study.
Mauck CK, Weiner DH, Ballagh SA, Creinin MD, Archer DF, Schwartz JL, Pymar HC, Lai JJ, Rencher WF, Callahan MM; CONRAD. Mauck CK, et al. Contraception. 2004 Jul;70(1):77-83. doi: 10.1016/j.contraception.2004.02.016. Contraception. 2004. PMID: 15208057 Free PMC article. Clinical Trial.
OBJECTIVES: To evaluate symptoms and signs of genital irritation, vaginal leakage and acceptability of polystyrene sulfonate (PSS), which is being studied as a vaginal contraceptive and microbicide. ...
OBJECTIVES: To evaluate symptoms and signs of genital irritation, vaginal leakage and acceptability of polystyrene sulfonate (PSS), w …
Palatability and physical properties of potassium-binding resin RDX7675: comparison with sodium polystyrene sulfonate.
Zann V, McDermott J, Jacobs JW, Davidson JP, Lin F, Korner P, Blanks RC, Rosenbaum DP. Zann V, et al. Drug Des Devel Ther. 2017 Sep 6;11:2663-2673. doi: 10.2147/DDDT.S143461. eCollection 2017. Drug Des Devel Ther. 2017. PMID: 28919716 Free PMC article. Clinical Trial.
BACKGROUND: Hyperkalemia is a potentially life-threatening condition that patients with heart failure or chronic kidney disease, especially those taking renin-angiotensin-aldosterone system inhibitors, are at high risk of developing. Sodium polystyrene sulfonate (SPS), a c …
BACKGROUND: Hyperkalemia is a potentially life-threatening condition that patients with heart failure or chronic kidney disease, especially …
Effect of sodium polystyrene sulfonate on lithium bioavailability.
Bélanger DR, Tierney MG, Dickinson G. Bélanger DR, et al. Ann Emerg Med. 1992 Nov;21(11):1312-5. doi: 10.1016/s0196-0644(05)81893-1. Ann Emerg Med. 1992. PMID: 1416324 Clinical Trial.
STUDY OBJECTIVE: To examine the effect of a single dose of sodium polystyrene sulfonate and sorbitol on lithium absorption. DESIGN: Prospective, randomized, crossover. ...CONCLUSION: Sodium polystyrene sulfonate and sorbitol may be used in patients immediately or sh …
STUDY OBJECTIVE: To examine the effect of a single dose of sodium polystyrene sulfonate and sorbitol on lithium absorption. DESIGN: P …
Calcium-Polystyrene Sulfonate Decreases Inter-Dialytic Hyperkalemia in Patients Undergoing Maintenance Hemodialysis: A Prospective, Randomized, Crossover Study.
Wang J, Lv MM, Zach O, Wang LY, Zhou MY, Song GR, Zhang X, Lin HL. Wang J, et al. Ther Apher Dial. 2018 Dec;22(6):609-616. doi: 10.1111/1744-9987.12723. Epub 2018 Aug 14. Ther Apher Dial. 2018. PMID: 30109784 Clinical Trial.
This clinical trial investigated the efficacy and safety of calcium-polystyrene sulfonate (Ca-PS) in MHD patients with interdialytic hyperkalemia. ...
This clinical trial investigated the efficacy and safety of calcium-polystyrene sulfonate (Ca-PS) in MHD patients with interdialytic …
Treatment of hyperkalemia in patients with chronic kidney disease: a comparison of calcium polystyrene sulphonate and sodium polystyrene sulphonate.
Nasir K, Ahmad A. Nasir K, et al. J Ayub Med Coll Abbottabad. 2014 Oct-Dec;26(4):455-8. J Ayub Med Coll Abbottabad. 2014. PMID: 25672163 Clinical Trial.
Medical management includes use of cation exchange resins to reduce the amount of excessive potassium from the body. Sodium polystyrene sulphonate (SPS) and calcium polystyrene sulphonate (CPS) are currently used for hyperklemia of CKD all over the world. ...
Medical management includes use of cation exchange resins to reduce the amount of excessive potassium from the body. Sodium polystyrene …
Fourteen-day safety and acceptability study of the universal placebo gel.
Schwartz JL, Ballagh SA, Kwok C, Mauck CK, Weiner DH, Rencher WF, Callahan MM. Schwartz JL, et al. Contraception. 2007 Feb;75(2):136-41. doi: 10.1016/j.contraception.2006.09.003. Epub 2006 Oct 25. Contraception. 2007. PMID: 17241844 Clinical Trial.
OBJECTIVE: This study evaluated the effect of the so-called universal placebo compared to the polystyrene sulfonate (PSS) placebo on genital irritation. DESIGN: A single-center, Phase I, randomized, closed-label study was performed to evaluate the genital irritation of mic …
OBJECTIVE: This study evaluated the effect of the so-called universal placebo compared to the polystyrene sulfonate (PSS) placebo on …
Potassium binders in hemodialysis patients: a friend or foe?
Chaaban A, Abouchacra S, Gebran N, Abayechi F, Hussain Q, Al Nuaimi N, Hassan ME. Chaaban A, et al. Ren Fail. 2013;35(2):185-8. doi: 10.3109/0886022X.2012.745118. Ren Fail. 2013. PMID: 23402387 Clinical Trial.
17 results